New competitor copies illegally and threatens lawsuit
Novo Nordisk criticizes Hims and Hers for planning to launch a copy of their weight-loss drug Wegovy. Novo brands this as “illegal mass production of pharmaceuticals,” citing a “significant risk to patient safety.” The Danish firm plans legal actions to protect patients and their intellectual property. Hims and Hers’ copy will be about $100 cheaper, […]